Cryotherapy Finds Application in the Treatment of Chronic Obstructive Pulmonary Disease with Chronic Bronchitis

     

Cryotherapy, sometimes known as cold therapy, is the use of extremely cold temperatures to deaden abnormal tissue or tumors. The cold coming from liquid nitrogen or arginine gas. This treatment merely damages the abnormal tissue only. This procedure is not advisable for adults or even children.

Cryotherapy for cancer treatments is more effective than radiation and chemotherapy. In cold therapy, physicians insert ultra-sound tubes into the affected area. The sound waves destroy abnormal tissue while inside the tubes. The recovery time after surgery is longer and sometimes, the cancer is inoperable even after successful surgery. During cold therapy, doctors use a special instrument called a cryoprobe. A cryoprobe is like a thick, colored vest that has a light on inside. As the patient lies in the cropland, the light shines onto the cervix. This causes the abnormal cells to die as they freeze in the dark.

Cryotherapy can be used in combination with chemotherapy and radiation therapy. There are two types of cold therapy; passive and active. In passive cold therapy, a catheter is inserted into the cancerous area through an incision in the neck. In the active method, a thin tube is passed through the incision but no catheter is necessary because the tube seals off the area where the procedure is to be done. The heat melts the abnormal cells, leaving the cervix and surrounding areas relatively normal.

Cryotherapy also finds application in the treatment of chronic obstructive pulmonary disease with chronic bronchitis. In December 2019, CSA Medical, Inc., a provider of innovative spray cryotherapy medical device solutions, received CE Mark approval for its RejuvenAir System, which applies metered cryospray of liquid nitrogen, for the treatment of chronic obstructive pulmonary disease with chronic bronchitis. The company can market the product in major EU countries such as the U.K. and Germany with the approval.